Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

7.94
+0.02000.25%
Post-market: 7.950.0100+0.13%19:30 EDT
Volume:819.46K
Turnover:6.60M
Market Cap:692.03M
PE:-3.73
High:8.23
Open:7.90
Low:7.79
Close:7.92
52wk High:36.26
52wk Low:6.65
Shares:87.16M
Float Shares:71.89M
Volume Ratio:0.72
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1289
EPS(LYR):-1.8700
ROE:-52.74%
ROA:-31.82%
PB:1.61
PE(LYR):-4.25

Loading ...

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 05

Waste Connections, Entergy, Bj’s, Olema, Tenet Insider Shock

TIPRANKS
·
Aug 01

Olema Pharma Insider Makes a Major Move With a Six-Figure Stock Sale

TIPRANKS
·
Jul 28

Olema Pharma Director Cyrus Harmon Sells $292,412 of Common Shares

Reuters
·
Jul 28

Is Olema Pharmaceuticals (OLMA) A Bargain After Its Russell Index Additions?

Simply Wall St.
·
Jul 03

Olema Grants Stock Options for 215,800 Shares to Eight New Employees Under Inducement Plan

Reuters
·
Jul 03

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 03

Olema Pharmaceuticals shareholders elect four directors at annual meeting

Reuters
·
Jun 24

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 09

LifeSci Capital Sticks to Its Buy Rating for Olema Pharmaceuticals (OLMA)

TIPRANKS
·
Jun 06

Analysts Offer Insights on Healthcare Companies: Olema Pharmaceuticals (OLMA), Jade Biosciences (JBIO) and Oculis Holding (OCS)

TIPRANKS
·
Jun 06

UBS Remains a Buy on Olema Pharmaceuticals (OLMA)

TIPRANKS
·
Jun 05

Olema grants 176,150 inducement stock options at $12.71 per share

Reuters
·
Jun 03

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 03

Olema Pharmaceuticals (OLMA) Gets a Buy from Guggenheim

TIPRANKS
·
Jun 01

Olema Pharmaceuticals: Buy Rating Reiterated as Pipeline Progress Supports Attractive Risk/Reward with Unchanged $62 Price Target

TIPRANKS
·
Jun 01

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Olema Pharmaceuticals (OLMA) and CG Oncology, Inc. (CGON)

TIPRANKS
·
May 26

Olema Pharmaceuticals, Bayer Collaborate to Test Potential Prostate Cancer Combination Therapy

MT Newswires Live
·
May 26

BUZZ-Olema Pharma climbs on collaboration agreement with Bayer

Reuters
·
May 26

Olema, Bayer launch OP-3136 prostate cancer collaboration

TIPRANKS
·
May 26